Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Vemurafenib × Clear all

NCT05068752 2024-09-19

Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms